HPV 检测和子宫颈抹片检查市场报告：2030 年趋势、预测和竞争分析

HPV 检测和子宫颈抹片检查的趋势和预测

到 2030 年，全球 HPV 检测和子宫颈抹片检查市场预计将达到 75 亿美元，2024 年至 2030 年复合年增长率为 6.5%。该市场的主要驱动因素是HPV病例数量的增加以及由此导致的子宫颈癌的增加、人们对子宫颈癌筛检工作的认识不断提高以及子宫颈癌研究和开发计划的资金筹措增加。全球 HPV 检测和子宫颈抹片检查市场的未来充满希望，医院/诊所和实验室市场也充满机会。

HPV 检测与子宫颈抹片检查市场洞察

Lucintel 预测，由于市场参与企业的投资增加以及与阴道癌相比子宫颈癌的发生率较高，子宫颈癌筛检在预测期内将继续占据很大一部分。我是。

在预测期内，北美仍将是最大的地区，因为对子宫颈癌早期检测的高度认识、既定的筛检建议以及有利的医疗保健报销环境推动了扩张。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球 HPV 和子宫颈抹片检查市场预计将达到 75 亿美元。

Q2.市场成长预测如何？

A2. 预计 2024 年至 2030 年，全球 HPV 检测和子宫颈抹片检查市场将以 6.5% 的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是 HPV 病例和相关子宫颈癌数量的增加、人们对子宫颈癌筛检措施的认识不断提高以及子宫颈癌研究和开发计划的资金筹措增加。

Q4.市场的主要细分市场是什么？

A4. 全球 HPV 检测和子宫颈抹片检查市场的未来前景看好，医院/诊所和实验室市场也充满机会。

Q5.市场上主要企业有哪些？

A5.HPV检测和子宫颈抹片检查的主要企业如下。

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

Q6.未来最大的细分市场是什么？

A6.Lucintel预计，由于市场参与企业对该行业的投资增加以及子宫颈癌的发生率高于阴道癌，子宫颈癌筛检在预测期内将继续增加，我们预测这将继续是一个很大的细分市场。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 在预测期内，北美将继续成为最大的地区，因为对子宫颈癌早期检测的高度认识、既定的筛检建议以及有利的医疗保健报销环境推动了扩张。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球 HPV 检测和子宫颈抹片检查检测市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球HPV检测和子宫颈抹片检查市场趋势（2018-2023）和预测（2024-2030）
• 按测试类型分類的全球 HPV 检测和子宫颈抹片检查测试市场
  • 子宫颈抹片检查
  • HPV检测
• 按产品分類的全球 HPV 检测和子宫颈抹片检查测试市场
  • 装置
  • 消耗品
  • 服务
• 全球 HPV 检测和子宫颈抹片检查测试市场（按应用）
  • 子宫颈癌筛检
  • 阴道癌筛检
• 按最终用途分類的全球 HPV 检测和子宫颈抹片检查测试市场
  • 医院和诊所
  • 实验室
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球 HPV 检测和子宫颈抹片检查检查市场（按地区）
• 北美 HPV 检测和子宫颈抹片检查市场
• 欧洲HPV检测及子宫颈抹片检查检测市场
• 亚太地区 HPV 检测和子宫颈抹片检查检查市场
• 其他地区HPV检测及子宫颈抹片检查检测市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球 HPV 检测和子宫颈抹片检查检测市场成长机会（按检测类型）
  • 全球 HPV 检测和子宫颈抹片检查试验市场成长机会（按产品）
  • 全球 HPV 检测和子宫颈抹片检查试验市场成长机会（按应用）
  • 全球 HPV 检测和子宫颈抹片检查试验市场成长机会（以最终用途）
  • 全球 HPV 检测和子宫颈抹片检查试验市场成长机会（按地区）
• 全球 HPV 检测和子宫颈抹片检查检测市场的新兴趋势
• 战略分析
  • 新产品开发
  • 全球HPV检测与子宫颈抹片检查检测市场容量扩张
  • 全球 HPV 检测和子宫颈抹片检查市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

HPV Testing and Pap Test Trends and Forecast

The future of the global HPV Testing and Pap Test market looks promising with opportunities in the hospitals & clinics and laboratories market. The global HPV Testing and Pap Test market is expected to reach an estimated $7.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are growing HPV cases and the ensuing rise in cervical cancer, increasing awareness of initiatives for screening for cervical cancer, and rising financing for cervical cancer research and development projects.

A more than 150-page report is developed to help in your business decisions.

HPV Testing and Pap Test by Segment

The study includes a forecast for the global HPV Testing and Pap Test by test type, product, application, end use, and region.

HPV Testing and Pap Test Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Pap Test
• HPV Test

HPV Testing and Pap Test Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

HPV Testing and Pap Test Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cervical Cancer Screening
• Vaginal Cancer Screening

HPV Testing and Pap Test Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Laboratories
• Others

HPV Testing and Pap Test Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of HPV Testing and Pap Test Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HPV Testing and Pap Test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HPV Testing and Pap Test companies profiled in this report include-

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

HPV Testing and Pap Test Market Insights

Lucintel forecasts that cervical cancer screening will remain the larger segment over the forecast period due to growing market participants' investments in the industry, and greater occurrences of cervical cancer compared to vaginal cancer.

North America will remain the largest region over the forecast period due to high awareness of cervical cancer early detection, well-established screening recommendations, and a good healthcare reimbursement environment are driving expansion.

Features of the Global HPV Testing and Pap Test Market

Market Size Estimates: HPV testing and pap test market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HPV testing and pap test market size by various segments, such as by test type, product, application, end use, and region in terms of value ($B).

Regional Analysis: HPV testing and pap test market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test type, product, application, end use, and regions for the HPV Testing and Pap Test market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HPV Testing and Pap Test market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HPV Testing and Pap Test market size?

Answer: The global HPV Testing and Pap Test market is expected to reach an estimated $7.5 billion by 2030.

Q2. What is the growth forecast for HPV Testing and Pap Test market?

Answer: The global HPV Testing and Pap Test market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HPV Testing and Pap Test market?

Answer: The major drivers for this market are growing HPV cases and the ensuing rise in cervical cancer, increasing awareness of initiatives for screening for cervical cancer, and rising financing for cervical cancer research and development projects.

Q4. What are the major segments for HPV Testing and Pap Test market?

Answer: The future of the global HPV Testing and Pap Test market looks promising with opportunities in the hospitals & clinics and laboratories market.

Q5. Who are the key HPV Testing and Pap Test market companies?

Answer: Some of the key HPV Testing and Pap Test companies are as follows.

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

Q6. Which HPV Testing and Pap Test market segment will be the largest in future?

Answer: Lucintel forecasts that cervical cancer screening will remain the larger segment over the forecast period due to growing market participants' investments in the industry, and greater occurrences of cervical cancer compared to vaginal cancer.

Q7. In HPV Testing and Pap Test market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high awareness of cervical cancer early detection, well-established screening recommendations, and a good healthcare reimbursement environment are driving expansion.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the HPV Testing and Pap Test market by test type (pap test and HPV test), product (instruments, consumables, and services), application (cervical cancer screening and vaginal cancer screening), end use (hospitals & clinics, laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HPV Testing and Pap Test Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global HPV Testing and Pap Test Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global HPV Testing and Pap Test Market by Test Type
  • 3.3.1: Pap Test
  • 3.3.2: HPV Test
• 3.4: Global HPV Testing and Pap Test Market by Product
  • 3.4.1: Instruments
  • 3.4.2: Consumables
  • 3.4.3: Services
• 3.5: Global HPV Testing and Pap Test Market by Application
  • 3.5.1: Cervical Cancer Screening
  • 3.5.2: Vaginal Cancer Screening
• 3.6: Global HPV Testing and Pap Test Market by End Use
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Laboratories
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global HPV Testing and Pap Test Market by Region
• 4.2: North American HPV Testing and Pap Test Market
  • 4.2.1: North American HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.2.2: North American HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.3: European HPV Testing and Pap Test Market
  • 4.3.1: European HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.3.2: European HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.4: APAC HPV Testing and Pap Test Market
  • 4.4.1: APAC HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.4.2: APAC HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.5: ROW HPV Testing and Pap Test Market
  • 4.5.1: ROW HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.5.2: ROW HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global HPV Testing and Pap Test Market by Test Type
  • 6.1.2: Growth Opportunities for the Global HPV Testing and Pap Test Market by Product
  • 6.1.3: Growth Opportunities for the Global HPV Testing and Pap Test Market by Application
  • 6.1.4: Growth Opportunities for the Global HPV Testing and Pap Test Market by End Use
  • 6.1.5: Growth Opportunities for the Global HPV Testing and Pap Test Market by Region
• 6.2: Emerging Trends in the Global HPV Testing and Pap Test Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global HPV Testing and Pap Test Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HPV Testing and Pap Test Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: QIAGEN
• 7.3: BD
• 7.4: Quest Diagnostics
• 7.5: Hologic
• 7.6: F. Hoffmann-La Roche
• 7.7: Femasys
• 7.8: Arbor Vita
• 7.9: NURX
• 7.10: Seegene